Genprex, inc.GNPX.US Overview
US StockHealthcare
(No presentation for GNPX)
GNPX Overall Performance
GNPX AI Analysis & Strategy
GNPX Recent Performance
-3.09%
Genprex, inc.
0.81%
Avg of Sector
-1.14%
S&P500
GNPX PowerScanner
GNPX Key Information
GNPX Valuation Metrics
GNPX Earnings Table
GNPX Profile
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.